February 23, 2017

Featured Post

[San Diego area] Are You Taking Prescription Warfarin or Coumadin?

Accriva Diagnostics, Inc. conducts evaluations of different blood analyzers. If you are currently taking Warfarin or Coumadin, you may qualify to participate in a study. Just 30 minutes of your time in a relaxed and friendly environment will be necessary to take the blood sample(s) from a vein in your arm. Each donor will be compensated $45 per visit. Please contact 858-263-2332 or email phlebotomy@accriva.com to see if you qualify.

Join Atrial Fibrillation (AF) Experts from Cleveland Clinic on March 6 to Get Your Afib Questions Answered

Our live chats with the Cleveland Clinic afib experts are always popular, so please join us for the next one.

Irregular or abnormal heart beats, called arrhythmias, occur when there are abnormal electrical impulses in your heart, causing your heart to beat too fast, too slow, or irregularly. Arrhythmias are very common and are often a mere annoyance, but they can also be responsible for life-threatening medical emergencies.

The most common irregular heart rhythm is called atrial fibrillation (AF or Afib) and involves the two upper chambers (atria) of the heart. Over 2 million Americans are affected by Afib, which is responsible for 15% of all strokes.

Treatment depends on the type and severity of the arrhythmia. Treatment options may include medications, lifestyle changes, invasive procedures, electrical devices or surgery. In some cases, no treatment will be necessary.

Take this opportunity to learn more about atrial fibrillation, including diagnosis and treatments, and have your questions answered by Walid Saliba, MD, Oussama Wazni, MD, and David Van Wagoner, PhD from the Cleveland Clinic, and Mellanie True Hills, Founder and CEO of StopAfib.org.

To learn more, see:  Atrial fibrillation experts from the Cleveland Clinic will answer your afib questions on March 6, 2017

Note: Please do not post your questions for the Cleveland Clinic doctors here.

Become an Atrial Fibrillation Advocate Mentor

UPDATE: All slots are filled. Thank you.

As a member of the Alliance for Aging Research’s Senior Patient and Family Caregiver Network Advisory Council, we at StopAfib.org have the opportunity to nominate atrial fibrillation advocates to participate in a six-month research-advocacy training program to empower senior patients and family caregivers to engage in patient-centered outcomes research.

Mellanie True Hills, CEO of StopAfib.org, will be involved in developing and teaching part of the program, and would love to have you participate.

If you’re interested, learn more at:

Extraordinary Opportunity to Become an Atrial Fibrillation Advocate Mentor

Do You Have Persistent or Longstanding Persistent Atrial Fibrillation? You May Qualify for the aMAZE Study

If you have persistent or longstanding persistent afib and are considering a catheter ablation, you may qualify to participate in the aMAZE Study. This study is for the purpose of determining if adding the LARIAT procedure before a catheter ablation can help. Learn more about the study at:

The aMAZE Study will evaluate the benefits of using the LARIAT procedure before catheter ablation

Holiday Special on the AfibAlert Monitor for Those Living with Atrial Fibrillation

AfibAlert — a standalone device that doesn’t require a smartphone — is available at a holiday special price of $199 throughout the month of December. Give yourself peace of mind this holiday season.

For more information...